ALLERGIC REACTIONS TO POLIDOCANOL FOR VEIN SCLEROSIS - 2 CASE-REPORTS

BACKGROUND. Polidocanol is a sclerosing solution that is highly valued by clinicians and patients for its painlessness, high efficacy, excellent safety profile, low incidence of side effects, and for the rarity of its allergic reactions. Previous estimates of the incidence of allergic reactions have ranged from 0 to 0.06%. OBJECTIVE. Improved recognition of systemic allergy to polidocanol is desirable for both clinicians and for patients. We have attempted to describe two cases recently observed in our population and to provide an improved upper-bounds estimate for the true population incidence of allergy to polidocanol, RESULTS. We report two recent cases of mild systemic allergic reaction to polidocanol in a population of 689 exposed patients, for an observed incidence of 0.3% in our patient population. We have calculated a 95% confidence upper-bound estimate of 0.91% for the incidence of polidocanol allergy in the general population. CONCLUSION. Allergy to polidocanol may be more common than previously recognized Careful questioning of previously treated patients and more prolonged observation of patients after treatment may yield a larger number of recognized cases.